J Homik
Overview
Explore the profile of J Homik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koller G, Goetz V, Vandermeer B, Homik J, McAlister F, Kendler D, et al.
Osteoporos Int
. 2020 Jul;
31(11):2093-2102.
PMID: 32613409
Osteoporosis is a chronic disease of low bone mass and fragility. Treatment is frequently compromised by suboptimal medication compliance causing increased morbidity. This review investigates adherence and persistence to parenteral...
2.
Knopp-Sihota J, Newburn-Cook C, Homik J, Cummings G, Voaklander D
Osteoporos Int
. 2011 Jun;
23(1):17-38.
PMID: 21660557
Vertebral collapse is a common fracture associated with osteoporosis. Subsequent pain may be severe and often requires medications and bed rest. Several studies have suggested the use of calcitonin for...
3.
Weinkauf J, Puttagunta L, Stewart K, Humar A, Homik J, Caldwell S, et al.
Transplant Proc
. 2010 Sep;
42(7):2707-10.
PMID: 20832574
Antineutrophil cytoplasmic antibody-associated vasculitis is a life-threatening disorder for which medical therapy has greatly improved survival. However, there is still significant mortality associated with antineutrophil cytoplasmic antibody-associated vasculitis. Little data...
4.
Suarez-Almazor M, Belseck E, Shea B, Homik J, Wells G, Tugwell P
Cochrane Database Syst Rev
. 2000 Oct;
(4):CD000959.
PMID: 11034691
Objectives: To assess the short-term efficacy and toxicity of antimalarials for the treatment of rheumatoid arthritis (RA). Search Strategy: We searched the Cochrane Musculoskeletal Group's trials register, the Cochrane Controlled...
5.
Suarez-Almazor M, Belseck E, Homik J, DORGAN M, Ramos-Remus C
Control Clin Trials
. 2000 Oct;
21(5):476-87.
PMID: 11018564
The objective of this study was to compare the performance of MEDLINE and EMBASE for the identification of articles regarding controlled clinical trials (CCTs) published in English and related to...
6.
Cranney A, Welch V, Adachi J, Homik J, Shea B, Suarez-Almazor M, et al.
Cochrane Database Syst Rev
. 2000 May;
(2):CD001983.
PMID: 10796457
Background: Corticosteroid-induced osteoporosis is a cause of morbidity in patients with chronic obstructive lung disease, asthma, and rheumatologic disorders. Corticosteroid treatment causes bone loss by a variety of complex mechanisms....
7.
Homik J, Cranney A, Shea B, Tugwell P, Wells G, Adachi R, et al.
Cochrane Database Syst Rev
. 2000 May;
(2):CD001347.
PMID: 10796432
Objectives: To assess the effects of bisphosphonates for the prevention and treatment of corticosteroid-induced osteoporosis. Search Strategy: We searched the Cochrane Musculoskeletal Group trials register, Medline up to 1997 and...
8.
Suarez-Almazor M, Belseck E, Shea B, Homik J, Wells G, Tugwell P
Cochrane Database Syst Rev
. 2000 May;
(2):CD000959.
PMID: 10796401
Objectives: To estimate the short-term efficacy and toxicity of antimalarials for the treatment of rheumatoid arthritis (RA). Search Strategy: We searched the Cochrane Musculoskeletal Group's trials register, the Cochrane Controlled...
9.
Homik J, Suarez-Almazor M, Shea B, Cranney A, Wells G, Tugwell P
Cochrane Database Syst Rev
. 2000 May;
(2):CD000952.
PMID: 10796394
Objectives: To assess the effects of calcium and vitamin D compared to calcium alone or placebo in the prevention of bone loss in patients taking systemic corticosteroids. Search Strategy: We...
10.
Suarez-Almazor M, Homik J
J Rheumatol
. 1999 Dec;
26(12):2505-8.
PMID: 10606352
No abstract available.